Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors
Julie W. Reeser(The Ohio State University), Sameek Roychowdhury(The Ohio State University Wexner Medical Center), Michele R. Wing(The Ohio State University), Jharna Miya(The Ohio State University), Marileila Varella‐Garcia(University of Colorado Anschutz Medical Campus), Dorrelyn M. Martin(The Ohio State University), Karan R. Naik(The Ohio State University), Joseph M. Gozgit(Akebia Therapeutics (United States)), Lianbo Yu(The Ohio State University), Dara L. Aisner(University of Colorado System), Aharon G. Freud(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Eliot Y. Zhu(The Ohio State University), Esko A. Kautto(The Ohio State University), Hannah Parks(The Ohio State University), Nicholas B. Nowacki(The Ohio State University), Matthew Reeder(The Ohio State University), Amy Smith(The Ohio State University), Joshua F. Coleman(The Ohio State University), Eric Samorodnitsky(The Ohio State University), Kurtis D. Davies(University of Colorado Anschutz Medical Campus), E. Lyon(The Ohio State University)
Cited by 79
Related Papers
Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2005|1.6k
Landscape of Microsatellite Instability Across 39 Cancer Types
|JCO Precision Oncology|2017|1.5k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k